RNVONovo Nordisk Tokenized Stock (Reality)
Stock 24/7/365Issued by Reality
Novo Nordisk is a Denmark-based global healthcare company focused on diabetes, obesity, rare blood disorders and endocrine diseases. Its GLP-1 portfolio gives it a central position in metabolic disease treatment, with growth tied to manufacturing expansion, indication broadening, competition and reimbursement dynamics in major markets.
- Macro context: RNVO is part of the tokenized equities market, which represents only ~0.002% of global listed equity today.
Data as of Nov 1, 2026
Price performance
7D
+3.22%
14D
+4.71%
30D
—
1Y
—
All-time
-7.31%
Key facts
via /coins/{id}Market Cap Rank
#4540
Circulating Supply
7.16K
Total Supply
7.16K
All-Time High
$43.65 · 2026-09-18
Categories
News & Insights
Also tokenized by
Novo Nordisk Tokenized Stock (Reality) is issued as 6 separate tokens across different issuers.
NVOON
NVOX
NVOC
NVOAlerts & digests
Coming soonReal-time price, NAV, mint, redemption alerts
Get pinged the moment RNVO crosses a price or spread threshold you set, or automated.
Breaking news alerts
Issuer, regulatory and depeg news for RNVO — the second it drops.
Daily summary
A once-a-day digest of RNVO's price, best yield and market moves in your inbox.
Analyze & download 24/7 history
Full round-the-clock historical data for RNVO — including off-market-hours — exportable to CSV.
Analyse with insight & news
AI-assisted analysis of RNVO paired with the latest issuer, regulatory and market news.